CN113419000A - Method for identifying panax notoginseng with 25 heads and less than 80 heads based on non-targeted metabonomics - Google Patents

Method for identifying panax notoginseng with 25 heads and less than 80 heads based on non-targeted metabonomics Download PDF

Info

Publication number
CN113419000A
CN113419000A CN202110667454.4A CN202110667454A CN113419000A CN 113419000 A CN113419000 A CN 113419000A CN 202110667454 A CN202110667454 A CN 202110667454A CN 113419000 A CN113419000 A CN 113419000A
Authority
CN
China
Prior art keywords
panax notoginseng
heads
metabolites
data
targeted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110667454.4A
Other languages
Chinese (zh)
Other versions
CN113419000B (en
Inventor
周严严
李明利
高波
罗川
边宝林
赵海誉
胡雨
王宏洁
司南
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui China Resources Jinchan Pharmaceutical Co Ltd
Institute of Materia Medica of CACMS
Original Assignee
Anhui China Resources Jinchan Pharmaceutical Co Ltd
Institute of Materia Medica of CACMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui China Resources Jinchan Pharmaceutical Co Ltd, Institute of Materia Medica of CACMS filed Critical Anhui China Resources Jinchan Pharmaceutical Co Ltd
Priority to CN202110667454.4A priority Critical patent/CN113419000B/en
Publication of CN113419000A publication Critical patent/CN113419000A/en
Application granted granted Critical
Publication of CN113419000B publication Critical patent/CN113419000B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8675Evaluation, i.e. decoding of the signal into analytical information
    • G01N30/8679Target compound analysis, i.e. whereby a limited number of peaks is analysed

Landscapes

  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Library & Information Science (AREA)
  • Engineering & Computer Science (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

本发明提供一种基于非靶向代谢组学鉴别25头与80头以下三七的方法,属于中药材分析检测领域,包括以下步骤:S1、以甲醇溶液为溶剂浸提三七代谢产物,得到供试品;S2、采用UHPLC LTQ Oribitrap MS联用技术对三七代谢产物提取液进行非靶向成分测定,得到原始数据;S3、对原始数据依次进行预处理和多元统计学分析;S4、以变量重要性投影指标为筛选指标筛选差异性代谢物;本发明基于三七整体性分析,以UHPLC LTQ Oribitrap MS技术结合非靶向代谢组学,并结合主成分分析筛选不同规格三七差异性代谢物,可用于准确区分不同商品规格三七,为三七市场药材商品规格标准提供理论依据。

Figure 202110667454

The invention provides a method for identifying 25 heads and less than 80 heads of Panax notoginseng based on non-targeted metabolomics, which belongs to the field of analysis and detection of traditional Chinese medicinal materials, and includes the following steps: S1. Using methanol solution as a solvent to extract the metabolites of Panax notoginseng to obtain Test sample; S2. UHPLC LTQ Oribitrap MS combined technology is used to determine the non-targeted components of the extract of Panax notoginseng metabolites to obtain the original data; S3. The original data is subjected to preprocessing and multivariate statistical analysis in turn; S4. The variable importance projection index is a screening index to screen differential metabolites; the present invention is based on the overall analysis of Panax notoginseng, uses UHPLC LTQ Oribitrap MS technology combined with non-targeted metabolomics, and combines principal component analysis to screen differential metabolism of Panax notoginseng of different specifications It can be used to accurately distinguish different commodity specifications of Panax notoginseng, and provide a theoretical basis for the specifications and standards of medicinal materials in the Panax notoginseng market.

Figure 202110667454

Description

Method for identifying panax notoginseng with 25 heads and less than 80 heads based on non-targeted metabonomics
Technical Field
The invention relates to the field of analysis and detection of traditional Chinese medicinal materials, in particular to a method for identifying panax notoginseng with 25 heads and panax notoginseng with less than 80 heads based on non-targeted metabonomics.
Background
Notoginseng is also named as radix linderae and radix stephaniae tetrandrae, is the dried root and rhizome of Panax notoginseng (Araliaceae) Panax notoginseng (Burk.) F.H.Chen, has very wide clinical application in Chinese medicine, and is also the traditional rare Chinese medicine and incised wound medicine in China. Pseudo-ginseng is sweet in nature and taste, slightly bitter and warm, enters liver and stomach meridians, and has the functions and main indications of dissipating blood stasis, stopping bleeding, diminishing swelling and relieving pain. Can be used for treating hemoptysis, hematemesis, epistaxis, hematochezia, metrorrhagia, traumatic hemorrhage, thoracico-abdominal pain, and traumatic injury with swelling and pain.
According to records of seventy-six medicinal material commodity specification standards issued by the ministry, the pseudo-ginseng specification grades can be graded according to the harvesting season, the medicinal parts and the sizes (weight) of the medicinal materials; in the market, the weight of the main root of pseudo-ginseng is the main way to distinguish different grades of pseudo-ginseng, and the price difference of pseudo-ginseng with different sizes (weights) is very large.
At present, the researches on the internal components of pseudo-ginseng with different sizes (weights) are less, the researches mainly comprise the steps of measuring the polysaccharide content of the pseudo-ginseng by using a phenol-sulfuric acid method, measuring volatile components by using GC-MS (gas chromatography-mass spectrometry), and the like, and the researches do not provide clear internal components of the pseudo-ginseng as internal indexes for distinguishing commercial medicinal materials, so that the practical significance is realized for exploring the difference metabolites of the pseudo-ginseng with different sizes and specifications and searching the internal component indexes of the pseudo-ginseng.
Disclosure of Invention
Aiming at the problems, the invention provides a method for identifying panax notoginseng with 25 heads and panax notoginseng below 80 heads based on non-targeted metabonomics, which aims to integrate ultra-high performance liquid chromatography-linear ion trap-electrostatic field orbit trap mass spectrum combined technology (UHPLC LTQ Oribitrap MS) and non-targeted metabonomics means to mine mass spectrum data of 25 heads of panax notoginseng and panax notoginseng below 80 heads, screen differential metabolites of the mass spectrum data and provide basis for standardizing the commodity specification standard of medicinal materials in the panax notoginseng market.
The purpose of the invention is realized by adopting the following technical scheme:
a method for identifying 25-80 pseudo-ginseng based on non-targeted metabonomics comprises the following steps:
s1, extracting metabolites of the pseudo-ginseng sample;
leaching the pseudo-ginseng metabolite by using a methanol solution as a solvent to obtain a test sample;
s2, measuring non-target components;
performing non-targeted component determination on the pseudo-ginseng metabolite extracting solution by adopting a UHPLC (ultra high performance liquid chromatography) LTQ Oribitrap MS (Mass Spectrometry) combined technology to obtain original data;
s3, processing and analyzing data
Sequentially carrying out pretreatment and multivariate statistical analysis on the original data;
s4, finding differential metabolites through data mining;
and (4) screening differential metabolites by taking the variable importance projection indexes as screening indexes.
Preferably, the extraction method in step S1 comprises pulverizing radix Notoginseng, sieving with 40 mesh sieve, weighing sieved radix Notoginseng powder 0.600g, adding 20ml 70% methanol solution, ultrasonic extracting for 40min, separating extractive solution, and filtering the extractive solution with 0.22 μm microporous membrane to obtain the sample.
Preferably, the measuring method in step S2 is specifically:
chromatographic conditions are as follows: waters ACQUITY UPLC HSS T3 chromatographic column with specification of 2.1mm × 100mm, 1.8 μm; the mobile phase A is an aqueous solution containing 0.1 percent of formic acid, the mobile phase B is acetonitrile, the elution gradient is 0-8min, and the concentration of the mobile phase A is 98-65 percent; 8-19min, 65-60% A, 19-27min, 60-10% A; 27-30min, 10% A; the column temperature is 30 ℃, the flow rate is 0.3ml/min, and the sample injection amount is 3 mul; mass spectrum conditions: the ion source is an electrospray ionization source, the positive ion mode and the negative ion mode are respectively scanned, the temperature of the heater is 350 ℃, the temperature of the capillary tube is 350 ℃, the voltage of the capillary tube is 35V, the spraying voltage is 3.5kV, the flow rate of sheath gas is 40arb, and the flow rate of auxiliary gas is 10 arb; performing full scanning on the primary mass spectrum of the test solution and the reference solution in an FT mode, wherein the scanning range is 100-1200, and the secondary mass spectrum adopts data-dependent scanning; mass spectral data were collected and analyzed using Xcalibur software.
Preferably, the preprocessing in step S3 is to extract mass spectrum data of 25 and 80 or less notoginseng collected by UHPLC LTQ Oribitrap MS through Progenesis QI software, and perform preprocessing including peak alignment, data normalization and quality control on the data;
preferably, the multivariate statistical analysis comprises principal component analysis, specifically, the preprocessed data is imported into Ezinfo software, and the principal component analysis method is used for analyzing the category, similarity and difference of the samples to characterize the differences of the samples.
Preferably, the variable importance projection indexes in step S4 include p value, vip value and Fold Change value, components with p value less than 0.05, vip > 1 and Fold Change > 1.5 are screened, components with high and low crossover in 25-head groups and 80-head or lower-head groups are further eliminated, and finally, differential metabolites of 25-head and 80-head or lower-head pseudo-ginseng groups are established.
The invention has the beneficial effects that:
(1) the invention is based on the panax notoginseng integrity analysis, carries out non-target metabolism total component detection on panax notoginseng from the alcohol extract angle, can accurately distinguish panax notoginseng with different commodity specifications by searching the panax notoginseng internal component indexes, using the integral difference and combining with the main component analysis to screen the different metabolites of panax notoginseng with different specifications, and provides theoretical basis for the panax notoginseng market medicinal material commodity specification standard.
(2) The non-targeted metabonomics is a research method for carrying out systematic and comprehensive analysis on the whole metabonomic group, obtaining data of a large amount of metabolites and searching for differential metabolites, and can be used for describing the difference between different types of medicaments.
(3) Compared with the traditional liquid mass (TOF MS and the like) detection, the UHPLC LTQ Oribitrap MS technology is adopted for data acquisition, so that higher mass number resolution and mass precision can be provided, high-accuracy mass number determination is realized, the mass number precision of a typical sample injection analyte is lower than 1ppm, and the limit of accurate quantitative identification of small molecular mass numbers is removed.
Drawings
The invention is further illustrated by means of the attached drawings, but the embodiments in the drawings do not constitute any limitation to the invention, and for a person skilled in the art, other drawings can be obtained on the basis of the following drawings without inventive effort.
FIG. 1 is a diagram showing the principal component analysis of 25 and 80 panax notoginseng under positive ion mode;
FIG. 2 is a diagram showing the principal component analysis of 25 and 80 panax notoginseng under negative ion mode;
FIG. 3 is a graph of the orthorhombic partial least squares discriminant analysis of 25 and 80 Notoginseng radix in positive ion mode;
FIG. 4 is a diagram of the orthorhombic partial least squares discriminant analysis of 25 and 80 Notoginseng radix in negative ion mode;
FIG. 5 is a heat map of positive ion pattern differential components;
FIG. 6 is a heat map of the differential composition of negative ion profile.
Detailed Description
The invention is further described with reference to the following examples.
The embodiment of the invention relates to a method for identifying 25-80 panax notoginseng based on non-targeted metabonomics, which comprises the following steps:
s1, extracting Notoginseng radix 25 and Notoginseng radix 80 below with 70% methanol;
s2, carrying out non-target component determination on 25 panax notoginseng heads and panax notoginseng heads below 80 by using UHPLC LTQ Oribitrap MS technology;
s3, extracting and analyzing the component information by using data processing software, and performing principal component analysis on the component information;
s4, finding differential metabolites through data mining;
specifically, the method comprises the following steps:
s1, extracting metabolites of the pseudo-ginseng sample;
collecting 25 batches of radix Notoginseng with different producing areas and 5 batches of radix Notoginseng with less than 80 heads for experiment, wherein the collected radix Notoginseng is radix Notoginseng with three years of growth and 2016 year of planting, and the producing areas of the radix Notoginseng are different; pulverizing Notoginseng radix, sieving with 40 mesh sieve, weighing sieved Notoginseng radix powder 0.600g, adding 20ml 70% methanol solution, ultrasonic extracting for 40min, separating extractive solution, and sieving with 0.22 μm microporous membrane to obtain 10 batches of Notoginseng radix metabolite extractive solution;
s2, measuring non-target components;
adopting UHPLC LTQ Oribitrap MS combined technology to carry out non-target component determination on the pseudo-ginseng metabolite extract, wherein the chromatographic conditions are as follows: waters ACQUITY UPLC HSS T3 chromatographic column with specification of 2.1mm × 100mm, 1.8 μm; the mobile phase A is an aqueous solution containing 0.1 percent of formic acid, the mobile phase B is acetonitrile, the elution gradient is 0-8min, and the concentration of the mobile phase A is 98-65 percent; 8-19min, 65% -60% A; 19-27min, 60% -10% A; 27-30min, 10% A; the column temperature is 30 ℃, the flow rate is 0.3ml/min, and the sample injection amount is 3 mul; mass spectrum conditions: the ion source is electrospray ionization (ESI), the positive and negative ion modes are scanned respectively, the heater temperature is 350 deg.C, the capillary voltage is 35V, the spray voltage is 3.5kV, and the sheath gas (N)2) Flow rate 40arb, auxiliary gas (N)2) Flow rate 10 arb; performing full scanning (with the resolution of 30000 and the m/z scanning range of 100-; collecting and analyzing mass spectrum data by using Xcalibur software;
s3, processing and analyzing data;
extracting mass spectrum data of panax notoginseng with 25 heads and less than 80 heads acquired by UHPLC LTQ Oribitrap MS by Progenisis QI software, preprocessing the data (including peak alignment, data normalization, quality control and the like), introducing the obtained data into Ezinfo software, analyzing the sample category, similarity and difference by methods such as principal component analysis and the like, representing the sample difference, and further mining the difference metabolites;
a large amount of multi-dimensional data can be converted into a scatter diagram which can be visually observed through the principal component score diagram, and the similarity and difference degree of observation variables are reflected by the distance between different observation samples;
s4, finding differential metabolites through data mining;
mining mass spectrum data of pseudo-ginseng with 25 heads and less than 80 heads, firstly calculating p values and FC (Fold Change) values of components by Progenis QI software, calculating vip values by orthogonal partial least squares (OPLS-DA) analysis, screening components with p values less than 0.05, vip more than 1 and Fold Change more than 1.5, obtaining 59 differential components in a positive ion mode, obtaining 83 differential components in a negative ion mode, specifically referring to Table 1, screening the obtained differential components, mainly calculating possible molecular formulas (most ppm is less than 10) by accurate molecular weight m/z for the identification method of the components without secondary fragments, and then comparing and identifying the possible molecular formulas with the identified components of the pseudo-ginseng in the literature; further removing components with high and low cross in the 25-head group and the groups of panax notoginseng below 80, removing components with low content and difficult peak area extraction, and finally establishing the differential metabolites of 25 boundary groups of 25 and panax notoginseng below 80, wherein the 25 components have high content in the panax notoginseng below 80, which is shown in table 2.
The heat map is used for visually representing the differential components, and the content difference of the found differential components between the two groups is found to be obvious.
TABLE 1 differential composition in Positive and negative ion modes
Figure BDA0003117434810000051
Figure BDA0003117434810000061
Figure BDA0003117434810000071
Figure BDA0003117434810000081
Figure BDA0003117434810000091
Table 2 establishes differential metabolites for the cut-off of 25 and 80 Notoginseng radix
Figure BDA0003117434810000092
And (3) identifying and verifying the following 25 and 80 panax notoginseng:
sample preparation: AG-25-1(25 pieces, Hebei Anguo medicinal materials market collection), AG-180-1(180 pieces, Hebei Anguo medicinal materials market collection)
The method comprises the following steps: the 25 and 80 panax notoginseng heads were collected and verified according to the aforementioned ingredient determination method with the 25 differential metabolites identified in table 2 to be able to distinguish the 25 and 80 panax notoginseng heads, the verification results are shown in table 3.
TABLE 3 validation of differential metabolites
Figure BDA0003117434810000101
Analyzing the data in table 3, it can be seen that 24 of the 25 different components have a higher content in the AG-180-1 (below 80) panax notoginseng than in the AG-25-1 (25) panax notoginseng, which meets the found rule of high or low content of 25 panax notoginseng and below 80 panax notoginseng; only the content of 5.68-409.1829 m/z in AG-180-1 (below 80) pseudo-ginseng is lower than that of AG-25-1 (25) pseudo-ginseng, which does not accord with the content rule determined in the early stage, and the total correct rate of the differential components screened by the method of the invention can reach 96%. Therefore, the differential metabolites screened by the method can well distinguish 25 panax notoginseng and 180 panax notoginseng in content.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention, and not for limiting the protection scope of the present invention, although the present invention is described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.

Claims (6)

1.一种基于非靶向代谢组学鉴别25头与80头以下三七的方法,其特征在于,包括以下步骤:1. a method for identifying 25 and 80 following Panax notoginseng based on non-targeted metabolomics, is characterized in that, comprises the following steps: S1、三七样品代谢产物的提取;S1. Extraction of metabolites from Panax notoginseng samples; 以甲醇溶液为溶剂浸提三七代谢产物,得到供试品;Extract the metabolites of Panax notoginseng with methanol solution as solvent to obtain the test product; S2、非靶向成分测定;S2. Determination of non-targeted components; 采用UHPLC LTQ Oribitrap MS联用技术对三七代谢产物提取液进行非靶向成分测定,得到原始数据;Using UHPLC LTQ Oribitrap MS combined technology to determine the non-targeted components of the extracts of Panax notoginseng metabolites to obtain the original data; S3、数据的处理与分析;S3. Data processing and analysis; 对原始数据依次进行预处理和多元统计学分析;Perform preprocessing and multivariate statistical analysis on the original data in turn; S4、数据挖掘发现差异性代谢物;S4. Data mining finds differential metabolites; 以变量重要性投影指标为筛选指标筛选差异性代谢物。Differential metabolites were screened using the variable importance projection index as the screening index. 2.根据权利要求1所述的一种基于非靶向代谢组学鉴别25头与80头以下三七的方法,其特征在于,步骤S1的提取方法是将三七粉碎并过40目筛,称取过筛后的三七粉末0.600g,加入20ml的体积分数70%的甲醇溶液,超声提取40min,分离提取液,提取液过0.22μm微孔滤膜,得到供试品。2. a kind of method based on non-targeted metabolomics to identify 25 and less than 80 Panax notoginseng according to claim 1, is characterized in that, the extraction method of step S1 is to pulverize Panax notoginseng and pass 40 mesh sieves, Weigh 0.600g of sieved Panax notoginseng powder, add 20ml of 70% methanol solution by volume, extract by ultrasonic for 40min, separate the extract, and pass the extract through a 0.22μm microporous membrane to obtain the test sample. 3.根据权利要求1所述的一种基于非靶向代谢组学鉴别25头与80头以下三七的方法,其特征在于,步骤S2的测定方法具体是:3. a kind of method for identifying 25 heads and 80 heads of Panax notoginseng based on non-targeted metabolomics according to claim 1, is characterized in that, the assay method of step S2 is specifically: 色谱条件:Waters ACQUITY UPLC HSS T3色谱柱,色谱柱规格2.1mm×100mm,1.8μm;流动相A为含0.1%甲酸的水溶液,流动相B为乙腈,洗脱梯度为0-8min,98%-65%A;8-19min,65%-60%A,19-27min,60%-10%A;27-30min,10%A;柱温30℃,流速0.3ml/min,进样量3μl;质谱条件:离子源为电喷雾电离源,正、负离子模式分别扫描,加热器温度为350℃,毛细管温度为350℃,毛细管电压为35V,喷雾电压为3.5kV,鞘气流速40arb,辅助气流速10arb;供试品和对照品溶液一级质谱在FT模式下进行全扫描,扫描范围100-1200,二级质谱采用数据依赖性扫描;质谱数据采用Xcalibur软件采集和分析。Chromatographic conditions: Waters ACQUITY UPLC HSS T3 column, column size 2.1mm×100mm, 1.8μm; mobile phase A is an aqueous solution containing 0.1% formic acid, mobile phase B is acetonitrile, elution gradient is 0-8min, 98%- 65%A; 8-19min, 65%-60%A, 19-27min, 60%-10%A; 27-30min, 10%A; column temperature 30℃, flow rate 0.3ml/min, injection volume 3μl; Mass spectrometry conditions: the ion source was an electrospray ionization source, the positive and negative ion modes were scanned separately, the heater temperature was 350 °C, the capillary temperature was 350 °C, the capillary voltage was 35V, the spray voltage was 3.5kV, the sheath gas flow rate was 40arb, and the auxiliary gas flow rate was 10arb; first-level mass spectrometry of the test substance and reference substance solution was fully scanned in FT mode, with a scan range of 100-1200, and second-level mass spectrometry was data-dependent scanning; mass spectrometry data were collected and analyzed by Xcalibur software. 4.根据权利要求1所述的一种基于非靶向代谢组学鉴别25头与80头以下三七的方法,其特征在于,步骤S3中所述预处理是通过Progenesis QI软件提取UHPLC LTQ OribitrapMS采集到的25头和80头以下三七的质谱数据,并对数据进行包括峰对齐、数据归一化和质控的预处理。4. a kind of method for identifying 25 heads and following 80 heads of Panax notoginseng based on non-targeted metabolomics according to claim 1, is characterized in that, the pretreatment described in step S3 is to extract UHPLC LTQ OribitrapMS by Progenesis QI software The collected mass spectrometry data of Panax notoginseng with 25 heads and 80 heads and below were subjected to preprocessing including peak alignment, data normalization and quality control. 5.根据权利要求1所述的一种基于非靶向代谢组学鉴别25头与80头以下三七的方法,其特征在于,所述多元统计学分析包括主成分分析,具体是将预处理得到的数据导入到Ezinfo软件,通过主成分分析方法对样品类别、相似性、差异性进行分析,表征样品差异。5. a kind of method based on non-targeted metabolomics to identify 25 and less than 80 Panax notoginseng according to claim 1, it is characterised in that the multivariate statistical analysis comprises principal component analysis, specifically the preprocessing The obtained data was imported into Ezinfo software, and the sample type, similarity and difference were analyzed by principal component analysis method to characterize the sample differences. 6.根据权利要求1所述的一种基于非靶向代谢组学鉴别25头与80头以下三七的方法,其特征在于,步骤S4中所述变量重要性投影指标包括p值、vip值和Fold Change值,使用Progenesis QI软件计算成分p值、Fold Change值,通过正交偏最小二乘判别分析计算vip值,首先筛选p值<0.05,vip>1,Fold Change>1.5的成分,再进一步剔除在25头组和80头以下三七组中存在含量高低交叉的成分,最终确立界分25头和80头以下三七的差异性代谢物。6. a kind of method for identifying 25 heads and 80 heads of Panax notoginseng based on non-targeted metabolomics according to claim 1, is characterized in that, the variable importance projection index described in step S4 comprises p value, vip value and Fold Change value, use Progenesis QI software to calculate component p value and Fold Change value, and calculate vip value through orthogonal partial least squares discriminant analysis. The components with overlapping contents in the 25-head group and the less than 80-head Panax notoginseng group were further eliminated, and the differential metabolites of Panax notoginseng were finally established.
CN202110667454.4A 2021-06-16 2021-06-16 Method for identifying panax notoginseng with 25 heads and less than 80 heads based on non-targeted metabonomics Active CN113419000B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110667454.4A CN113419000B (en) 2021-06-16 2021-06-16 Method for identifying panax notoginseng with 25 heads and less than 80 heads based on non-targeted metabonomics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110667454.4A CN113419000B (en) 2021-06-16 2021-06-16 Method for identifying panax notoginseng with 25 heads and less than 80 heads based on non-targeted metabonomics

Publications (2)

Publication Number Publication Date
CN113419000A true CN113419000A (en) 2021-09-21
CN113419000B CN113419000B (en) 2022-11-29

Family

ID=77788783

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110667454.4A Active CN113419000B (en) 2021-06-16 2021-06-16 Method for identifying panax notoginseng with 25 heads and less than 80 heads based on non-targeted metabonomics

Country Status (1)

Country Link
CN (1) CN113419000B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114814057A (en) * 2022-04-28 2022-07-29 湖南省药品检验检测研究院 Method for distinguishing true and false of selaginella tamariscina varieties through non-targeted metabonomics and application
CN115112798A (en) * 2022-06-28 2022-09-27 中国中医科学院中药研究所 Method for evaluating quality of panax notoginseng based on LC-MS and GC-MS non-targeted metabonomics

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107941939A (en) * 2017-11-20 2018-04-20 哈尔滨工业大学 A kind of method that organic rice and non-organic rice are distinguished using metabonomic technology
CN111323509A (en) * 2020-03-24 2020-06-23 中国农业科学院农业基因组研究所 Plant sex identification method based on metabolome global analysis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107941939A (en) * 2017-11-20 2018-04-20 哈尔滨工业大学 A kind of method that organic rice and non-organic rice are distinguished using metabonomic technology
CN111323509A (en) * 2020-03-24 2020-06-23 中国农业科学院农业基因组研究所 Plant sex identification method based on metabolome global analysis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHANG-JIANG-SHENG LAI 等: "An integrated high resolution mass spectrometric data acquisition method for rapid screening of saponins in Panax notoginseng (Sanqi)", 《JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS》 *
张银 等: "基于代谢组学研究熟三七发挥补血作用的机制", 《中国中药杂志》 *
贾丽: "基于离线三维色谱-高分辨质谱与代谢组学技术的人参花、西洋参花、三七花系统物质基础及其差异比较研究", 《中国优秀博硕士学位论文全文数据库(硕士) 医药卫生科技辑》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114814057A (en) * 2022-04-28 2022-07-29 湖南省药品检验检测研究院 Method for distinguishing true and false of selaginella tamariscina varieties through non-targeted metabonomics and application
CN114814057B (en) * 2022-04-28 2024-01-16 湖南省药品检验检测研究院 A method and application of non-targeted metabolomics to distinguish the authenticity of Selaginella species
CN115112798A (en) * 2022-06-28 2022-09-27 中国中医科学院中药研究所 Method for evaluating quality of panax notoginseng based on LC-MS and GC-MS non-targeted metabonomics
CN115112798B (en) * 2022-06-28 2023-08-11 中国中医科学院中药研究所 A method for evaluating the quality of Panax notoginseng based on LC-MS and GC-MS non-targeted metabolomics

Also Published As

Publication number Publication date
CN113419000B (en) 2022-11-29

Similar Documents

Publication Publication Date Title
Peng et al. The difference of origin and extraction method significantly affects the intrinsic quality of licorice: A new method for quality evaluation of homologous materials of medicine and food
Chan et al. Ultra‐performance liquid chromatography/time‐of‐flight mass spectrometry based metabolomics of raw and steamed Panax notoginseng
CN109870515B (en) Traditional Chinese medicine identification method based on traditional Chinese medicine chromatogram-mass spectrum high-dimensional image database
CN105738546B (en) Method for establishing fingerprint of radix curcumae medicinal material and fingerprint thereof
CN107064319B (en) Determination method of HPLC characteristic chromatogram of Guizhou Codonopsis pilosula
CN110702813B (en) A kind of Miao medicine Heigu Teng HPLC fingerprint research and multi-component content determination method
CN113419000A (en) Method for identifying panax notoginseng with 25 heads and less than 80 heads based on non-targeted metabonomics
CN109270187A (en) A kind of Chinese materia medica preparation quality evaluating method based on metabolism group Yu full ingredient semi-quantitative analysis
Yang et al. Comparison of metabolomics of Dendrobium officinale in different habitats by UPLC-Q-TOF-MS
CN109444290B (en) Construction method and detection method of UPLC (ultra performance liquid chromatography) characteristic map of plantain herb
CN113759003B (en) Licorice origin distinguishing method based on UPLC fingerprint spectrum and chemometrics method
CN108896681B (en) Nerve-soothing brain-tonifying liquid multi-index quantitative fingerprint establishment method and application thereof
CN103115973B (en) A method for judging batch consistency of traditional Chinese medicine
CN113866293A (en) Method for rapidly identifying and analyzing chemical components in chamomile
Li et al. Chemical Differentiation and Quantitative Analysis of Different Types of Panax Genus Stem‐Leaf Based on a UPLC‐Q‐Exactive Orbitrap/MS Combined with Multivariate Statistical Analysis Approach
CN110297060B (en) Fingerprint detection method and fingerprint thereof for ixeris sonchifolia medicinal materials
CN115166121A (en) Method for identifying different processed rhizoma polygonati products based on GC-IMS analysis of characteristic odor substances
CN107576743B (en) Method for establishing fingerprint of Bining spray and fingerprint thereof
Meng et al. ASAP-MS combined with mass spectrum similarity and binary code for rapid and intelligent authentication of 78 edible flowers
CN113884597B (en) HPLC-IT-TOF/MS fingerprint detection method for endive and fingerprint thereof
CN106290643A (en) A kind of method of quality control of Chinese medicine Herba Schizonepetae anti-lung cancer activity composition
CN117334257A (en) Lucid ganoderma multi-level screening mass spectrum database and establishment method and application thereof
CN117368340A (en) LC-Q-TOF-based identification method of adulterated ginger processed pinellia tuber in ginger processed pinellia tuber
He et al. Development of image similarity strategy based on targeted filtration for non-targeted HS-SPME/GC× GC fingerprints of volatile oils from Chinese patent medicines: A case of Chaihu Shugan Wan
CN110823828A (en) Method for identifying Wumai green wormwood in different producing areas

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant